Sign In
Buy GERN
$1.16
-0.0100 (-0.85%)
At Close: Jun 03, 2026
Xconomy: Legend Biotech’s Upsized IPO Lands $424M for Multiple Myeloma Drug
08:52pm, Friday, 05'th Jun 2020
The biggest life sciences IPO of the year so far belongs to Legend Biotech. The cancer drug developer was able to raise $423.8 million after pricing its
Is Geron (GERN) Outperforming Other Medical Stocks This Year?
03:30pm, Friday, 05'th Jun 2020
Is (GERN) Outperforming Other Medical Stocks This Year?
Top Ranked Momentum Stocks to Buy for June 5th
11:29am, Friday, 05'th Jun 2020
Top Ranked Momentum Stocks to Buy for June 5th
Legend Biotech Corporation Announces Pricing of Initial Public Offering
12:00am, Friday, 05'th Jun 2020
Legend Biotech, a global clinical-stage biopharmaceutical company, today announced the pricing of its initial public offering.
Geron 13D Filing From Growth Equity Opportunities 17 Shows 9.6% Stake
07:06pm, Thursday, 04'th Jun 2020Top Ranked Momentum Stocks to Buy for June 2nd
01:08pm, Tuesday, 02'nd Jun 2020
Top Ranked Momentum Stocks to Buy for June 2nd
Cantor Fitzgerald Maintains Overweight on Geron, Raises Price Target to $4
11:13am, Monday, 01'st Jun 2020Geron Corporation (Delaware) (GERN) Q1 2020 Earnings Call Transcript
09:00pm, Friday, 29'th May 2020
Ladies and gentlemen, thank you for standing by, and welcome to the Q1 2020 Geron Earnings Conference Call. Also joining me today are Aleksandra Rizo, our Chief Medical Officer; and Anil Kapur, our H
Geron shares are trading higher after the company reported better-than-expected Q1 EPS and sales results.
12:48pm, Friday, 29'th May 2020B. Riley FBR Maintains Buy on Geron, Raises Price Target to $4
12:13pm, Friday, 29'th May 2020Edited Transcript of GERN earnings conference call or presentation 28-May-20 8:30pm GMT
02:52am, Friday, 29'th May 2020
Q1 2020 Geron Corp Earnings Call
Geron (GERN) Reports Q1 Loss, Lags Revenue Estimates
10:25pm, Thursday, 28'th May 2020
Geron (GERN) delivered earnings and revenue surprises of 11.11% and -52.73%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Geron Q1 EPS $(0.08) Beats $(0.12) Estimate, Sales $52.00K Beat $50.00K Estimate
08:10pm, Thursday, 28'th May 2020Geron Corporation Reports First Quarter 2020 Financial Results
08:05pm, Thursday, 28'th May 2020
MENLO PARK, Calif., May 28, 2020 -- Geron Corporation (Nasdaq: GERN) today reported financial results for the first quarter ended March 31, 2020. The Company will host a.
The Daily Biotech Pulse: PhaseBio To Start Potential Pivotal COVID-19 Trial, Immunomedics CEO Quits, Tetraphase Receives Sweetened Offer
12:00am, Thursday, 28'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 27)
ADC Therapeutics SA (NYSE:...
